Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 5/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.64 |
| ▸ | GRM5 | P41594 | 6/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12416415 | 0.91 | CYP1A2 (0.64) | CYP1A2CYP2C9GRM5CYP3A4KCNH2 | |
| SCHEMBL12412122 | 0.89 | GRM5 (0.67) | GRM5 | |
| SCHEMBL12412145 | 0.86 | CYP1A2 (0.62) | CYP1A2CYP2C9GRM5CYP3A4KCNH2 | |
| SCHEMBL12412496 | 0.83 | GRM4 (0.56) | CYP1A2CYP2C9GRM5CYP3A4KCNH2 | |
| SCHEMBL12416375 | 0.83 | GRM5 (0.77) | CYP1A2CYP2C9GRM5CYP3A4 | |
| SCHEMBL3637608 | 0.82 | CDK8 (0.66) | GRM5 | |
| SCHEMBL12412177 | 0.80 | CYP1A2 (0.54) | CYP1A2CYP2C9GRM5CYP3A4KCNH2 | |
| SCHEMBL12412170 | 0.80 | GRM5 (0.65) | CYP1A2CYP2C9GRM5CYP3A4KCNH2 | |
| SCHEMBL12412156 | 0.79 | GRM5 (0.62) | CYP1A2CYP2C9GRM5CYP3A4 | |
| SCHEMBL6927550 | 0.79 | GRM5 (0.79) | CYP1A2CYP2C9GRM5CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166158-A1 | SUBSTITUTED PHENYLAMINE CARBOXAMIDE ANALOGS AS MGLUR5 NEGATIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING THE SAME | VANDERBILT UNIVERSITY | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166158-A1 | SUBSTITUTED PHENYLAMINE CARBOXAMIDE ANALOGS AS MGLUR5 NEGATIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING THE SAME | GRM5, GRIK5, GRM2 | CYP1A2 3957/4885CYP2C9 3600/4885GRM5 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.